On Thursday, March 20th in Mountain View, BrainMind held a Startup Salon and “Fire Pit” night. We brought together entrepreneurs from the most innovative companies working at the intersection of the neuroscience, mind science, AI, and consciousness.
This private gathering brought together visionary entrepreneurs and investors for a magical evening—surrounded by thought-provoking conversations and cutting-edge neurotechnology.
This was a rare opportunity to engage directly with pioneering founders at the cutting edge of neurotechnology, AI, and mind science—where bold ideas and breakthrough innovations are shaping the future.
NeuroAI Panel
Hosted by Foresight Institute + Protocol Labs
HOSTS
PANELISTS
Featured Entrepreneurs
Casey Halpern, SynchNeuro
Divya Chander, Lucidify
Omer Burak Ericek, Neuro Artech Co
Deblina Sarkar, Nano-Cybernetic Biotrek Lab, MIT
Steve Gullans, Thynk Inc
Zach Lomis, Vantage
Gabriel Kreiman, Kreiman Lab, Harvard, Memorious
Ramses Alcaide, Neurable
Ryota Kanai, Japan Moonshot R&D Program
Mark Chevillet, Ruby Neurotech
“Fire Pit” Discussions
Neurotech Funding: Transforming the Art of the Possible
John Ngai, Director, NIH BRAIN Initiative (facilitator)
Jacques Carolan, Program Director, ARIA
Amy Kruse, General Partner, Satori Neuro
Justin Sanchez, Fellow at Battelle
David Markowitz, Chief Scientist, STR
Foundation Models of the Brain, Digital Twins, and NeuroAI
Andreas Tolias, Professor, Stanford
Gabriel Kreiman, Professor, Harvard Medical School
Talmo Pereira, Salk Fellow & Principal Investigator, Salk Institute for Biological Studies
Sean Escola, Neuro Lead, Protocol Labs
Allison Duettmann, CEO, Foresight Institute
Epigenetics, Parenting, and AI
Bianca Jones Marlin, Assistant Professor, Columbia & HHMI
Sará King, CEO and Founder, MindHeart AI
Jennifer Gentile, Chief Digital Health Officer and Staff Psychologist, Thynk, Harvard Medical School, Boston Children's Hospital
Wandering Minds to AI Creativity
Arnaud Delorme, Research Scientist, UCSD and IONS
Jonathan Schooler, Distinguished Professor, UCSB
Psychedelics: What’s Now and What’s Next?
Michael Brotherton, Managing Partner at Dragonfly 44 Capital
